Cargando…

Downregulated miR-130a enhances the sensitivity of acute myeloid leukemia cells to Adriamycin

MicroRNA (miR)-130a has been reported to promote cancer growth; however, its role during acute myeloid leukemia (AML) is not completely understood. In the present study, the effects of miR-130a on the sensitivity of AML cells to Adriamycin (Adr) were investigated. 5-Aza-2′-deoxycytidine (5-Aza-dC) w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Huimin, Liu, Min, Zhang, Jiangzhao, Liang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453506/ https://www.ncbi.nlm.nih.gov/pubmed/32945422 http://dx.doi.org/10.3892/mmr.2020.11375

Ejemplares similares

Downregulation of hypermethylated in cancer-1 by miR-4532 promotes adriamycin resistance in breast cancer cells
por: Feng, Fan, et al.
Publicado: (2018)

Long noncoding RNA ZFAS1 enhances adriamycin resistance in pediatric acute myeloid leukemia through the miR-195/Myb axis
por: Li, Qun, et al.
Publicado: (2019)

Clinical significance of miR-372 and miR-495 in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2020)

CircNPM1 strengthens Adriamycin resistance in acute myeloid leukemia by mediating the miR-345-5p/FZD5 pathway
por: Ding, Jie, et al.
Publicado: (2021)

RBM38 is negatively regulated by miR-320b and enhances Adriamycin resistance in breast cancer cells
por: Ke, Jing, et al.
Publicado: (2022)

MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1
por: Sun, Yan-ping, et al.
Publicado: (2016)

WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines
por: Ibrahim, Sara M., et al.
Publicado: (2019)

Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib
por: Ohyashiki, Kazuma, et al.
Publicado: (2016)

Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell
por: Ofori, Jones K., et al.
Publicado: (2017)

Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma
por: Yan, Shufang, et al.
Publicado: (2022)

MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death
por: Ding, Chao, et al.
Publicado: (2018)

Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia
por: Ganesan, Saravanan, et al.
Publicado: (2019)

miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia
por: Pei, Han Zhong, et al.
Publicado: (2023)

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013)

Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)

Mechanism of the enhancing effects of miR-93 on resistance of breast cancer MCF-7 cells to adriamycin
por: Wang, Qian, et al.
Publicado: (2018)

Prognostic value of miR-96 in patients with acute myeloid leukemia
por: Zhao, Jiangning, et al.
Publicado: (2014)

High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia
por: Liu, Yue, et al.
Publicado: (2023)

MiR-221 and miR-130a Regulate Lung Airway and Vascular Development
por: Mujahid, Sana, et al.
Publicado: (2013)

CircRNA CircEHBP1 Regulates the Maturation of MiR-129 to Increase the Chemoresistance of Cancer Cells to Adriamycin in Acute Myeloid Leukaemia
por: Li, Hong, et al.
Publicado: (2022)

Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia
por: Jia, Yan, et al.
Publicado: (2020)

Serum miR‐22 is a novel prognostic marker for acute myeloid leukemia
por: Qu, Hong, et al.
Publicado: (2020)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Plasma Levels of miR-27a, miR-130b, and miR-301a in Polycystic Ovary Syndrome
por: Pourteymour Fard Tabrizi, Zahra, et al.
Publicado: (2020)

Clinical Significance of MiR-130b and MiR-125b as Biomarkers in Hepatocellular Carcinoma
por: El-Naidany, Sherin Sobhy, et al.
Publicado: (2022)

miR-130b duplex (miR-130b-3p/miR-130b-5p) negatively regulates goat intramuscular preadipocyte lipid droplets accumulation by inhibiting Krüppel-like factor 3 expression
por: Li, Yanyan, et al.
Publicado: (2023)

CircRNA_0044556 diminishes the sensitivity of triple-negative breast cancer cells to adriamycin by sponging miR-145 and regulating NRAS
por: Chen, Jingjing, et al.
Publicado: (2022)

FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ
por: Wang, Meibin, et al.
Publicado: (2022)

miR-199b-5p mediates adriamycin-induced podocyte apoptosis by inhibiting the expression of RGS10
por: Qu, Gaoting, et al.
Publicado: (2021)

Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia
por: Zhou, Jing-dong, et al.
Publicado: (2018)

Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia
por: Tang, Xiaoqiong, et al.
Publicado: (2015)

Global proteomics dataset of miR-126 overexpression in acute myeloid leukemia
por: Schoof, Erwin M., et al.
Publicado: (2016)

Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia
por: Zhang, Piqiang, et al.
Publicado: (2020)

hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide
por: HE, JIN-HUA, et al.
Publicado: (2013)

Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia
por: Cao, Yang, et al.
Publicado: (2022)

Downregulation of miR-142a Contributes to the Enhanced Anti-Apoptotic Ability of Murine Chronic Myelogenous Leukemia Cells
por: Chen, Zhiwei, et al.
Publicado: (2021)

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
por: Srutova, Klara, et al.
Publicado: (2018)

Echinacoside Suppresses the Progression of Breast Cancer by Downregulating the Expression of miR-4306 and miR-4508
por: Bian, Peng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hs52nc23kb0as2p76ts6htu64c